Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01044966 | A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma | terminated | Phase 1 / Phase 2 | 12 | Medical University of South CarolinaOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT01048060 | Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure | terminated | — | 334 | Stanford UniversityOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT02491827 | Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours(Cleopatra) | terminated | — | 10 | Charalampaki, Cleopatra, M.D.INDIV | 1 | Feb 6, 2019 | clinicaltrials |
| NCT00179881 | Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma | completed | Phase 2 | 47 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03113799 | A Study Evaluate Aqueduct's Smart External Drain(SED) | completed | N/A | 56 | Aqueduct Critical CareINDUSTRY | 1 | Jan 31, 2019 | clinicaltrials |
| NCT02796729 | CEST- Glucose Enhanced MRI for Metastatic Brain Tumours | terminated | Phase 2 | 3 | British Columbia Cancer AgencyOTHER | 1 | Jan 28, 2019 | clinicaltrials |
| NCT03815838 | Molecular Imaging of Pituitary Adenomas(MIMOPA) | unknown | N/A | 20 | Cardiff UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00207298 | 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology | completed | — | 39,242 | British Columbia Cancer AgencyOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT02035852 | High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors | completed | — | 184 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 2, 2019 | clinicaltrials |
| NCT02941536 | Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer | completed | N/A | 40 | AC Camargo Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT01767415 | Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection | completed | Phase 1 / Phase 2 | 10 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 11, 2018 | clinicaltrials |
| NCT03754530 | Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation | unknown | Phase 2 | 162 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT03033706 | Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy | completed | N/A | 61 | Cairo UniversityOTHER | 1 | Nov 23, 2018 | clinicaltrials |
| NCT03717454 | Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Nov 20, 2018 | clinicaltrials |
| NCT00527657 | Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients | completed | Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT00199511 | Hypertonic Saline 75% vs Mannitol 20% | completed | N/A | 162 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00038389 | Study of Vioxx and Radiation Therapy for Brainstem Glioma | terminated | Phase 1 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT00038441 | Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas | completed | Phase 1 / Phase 2 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02713087 | Vasopressor Effects in Anesthetized Patients | completed | Phase 4 | 48 | University of AarhusOTHER | 1 | Oct 26, 2018 | clinicaltrials |
| NCT03719781 | Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery | unknown | — | 90 | Kocaeli UniversityOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT01977677 | Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma | completed | Phase 1 / Phase 2 | 30 | Lawrence RechtOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT03714763 | Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Oct 22, 2018 | clinicaltrials |
| NCT00329719 | Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma | completed | Phase 1 / Phase 2 | 115 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2018 | clinicaltrials |
| NCT02672241 | Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children | unknown | Phase 2 | 30 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03400865 | Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas | unknown | N/A | 30 | Zhebao WuOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT02253212 | Safety of BBB Opening With the SonoCloud(SONOCLOUD) | completed | Phase 1 / Phase 2 | 27 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT02489071 | Cognitive Intervention After a Brain Tumor | completed | N/A | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT00400816 | Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma | completed | Phase 2 | 29 | The Cleveland ClinicOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03675230 | Study of Tomotherapy HD in Medulloblastoma | unknown | N/A | 220 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT00433381 | Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma | completed | Phase 2 | 123 | National Cancer Institute (NCI)NIH | 1 | Sep 17, 2018 | clinicaltrials |
| NCT00085098 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | completed | Phase 3 | 24 | Children's Oncology GroupNETWORK | 4 | Sep 7, 2018 | clinicaltrials |
| NCT00754286 | A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer | completed | N/A | 132 | Albert Einstein College of MedicineOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT02129712 | Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors(CRPBT) | completed | N/A | 40 | Vanderbilt UniversityOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT03247127 | Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy | unknown | N/A | 30 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01510743 | Ultrasound Guided Central Vein Catheterization and Complications | completed | N/A | 1,484 | Seoul National University Bundang HospitalOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT01504399 | Rhinological Outcomes in Endonasal Pituitary Surgery | completed | — | 235 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT01967758 | Phase I Study of Safety and Immunogenicity of ADU-623 | completed | Phase 1 | 11 | Providence Health & ServicesOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03633552 | Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | unknown | Phase 3 | 62 | Mashhad University of Medical SciencesOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03014687 | Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions(POET) | recruiting | Phase 4 | 116 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT03630861 | Establishment of a Signature of Circulating microRNA as a Tool to Aid Diagnosis of Primary Brain Tumors in Adults(MIRNA) | completed | — | 160 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT03626818 | The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy | unknown | — | 125 | Guangdong Association of Clinical TrialsOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03619694 | Role of MR Spectroscopy in Brain Tumors | unknown | — | 100 | Assiut UniversityOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02389530 | Use of Fluorescein Dye for the Removal of Brain Tumors | completed | — | 91 | University of PittsburghOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT03615391 | Predictive Role and HuR Mechanisms of Regulation in the Brain Tumours(HUR) | unknown | — | 140 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT00679354 | Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 2 | Aug 1, 2018 | clinicaltrials |
| NCT01103375 | Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma | terminated | Phase 1 | 5 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT01151670 | Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors | completed | Phase 1 | 18 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2018 | clinicaltrials |
| NCT01575275 | Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme | terminated | Phase 2 | 8 | Michael Vogelbaum, MD, PhDOTHER | 1 | Jul 31, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Feb 12, 2019source: clinicaltrials